Bruce Flatt: Strength to Act When Others Cannot
Bruce Flatt’s Brookfield built 19 percent annual returns by buying distressed real assets below replacement cost with long-term non-recourse financing.
Bruce Flatt’s Brookfield built 19 percent annual returns by buying distressed real assets below replacement cost with long-term non-recourse financing.
Chevron nears $5 bn deal for Blackstone-backed oil producer in US Gulf $CVX
"expects sales to decrease 3.5% to 5.5%, which it said is primarily due to lower volumes in its beef segment" Tyson Foods Guides for Sales Decline as Beef Business Remains Under Pressure $TSN
Adobe (ADBE) became a full position at about $246, backed by buybacks and confidence it can adapt to AI competition.
Ondas reported $167.5 million in Q3 revenue but spent $562 million of cash, halved gross margin and fell below its $6 stop level.
Offshore Radar maps 160-plus listed offshore rigs, contracts, day rates and uncontracted capacity through 2029.
Travere Therapeutics' FILSPARI has two FDA approvals and is driving revenue growth, while TVTX shares have nearly tripled since August 2025.
Domino’s built PULSE, online ordering and Pizza Tracker into a delivery machine, driving 10% annual global retail sales growth after its…
Nubank and MercadoLibre update target prices as Brazil’s 9% real rates, weaker currency and tighter credit favor their cost advantages and…
Floor & Decor has logged 20 straight quarters of comp transaction declines, with Q3 quarter-to-date same-store sales down about 3.8% as…
TPG trades 20% below its average distributable-earnings multiple despite the fastest fee-related earnings growth among alternative…
CDW CEO Chris Leahy says AI spending is entering a second wave focused on putting technology to work in everyday consumption.
American Tower’s wireless network stayed operational during the FAA ground stop, while CoreSite lifted its 2026 data center revenue growth…
Regeneron Q3 revenue rose 36% to $5.1 billion as Sanofi collaboration revenue jumped 68%, while EYLEA US sales fell 41%.
Sanofi Q3 sales rose 14.3% at constant currency to €14.4 billion, led by 34.8% Dupixent growth, prompting a second increase to FY26…
AstraZeneca reported Q3 revenue of $16.2 billion, up 7%, with oncology up 17% and core EPS beating expectations; Farxiga sales fell 25%…
Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…
Marvell’s all-stock Lumentum deal exposes LITE holders to MRVL volatility while paying peak-cycle AI multiples, with US and China antitrust…
Transocean enters its Valaris merger with 109 of 110 available deepwater rigs contracted and 313 million shares sold short, despite weaker…
Enterprise Products Partners has pulled growth spending into 2026, while Energy Transfer’s contracted projects offer clearer EBITDA growth…
Intel maintained after its post-earnings sell-off, with AI inference CPU demand and foundry customer announcements expected to drive a…
Marvell’s proposed Lumentum deal risks alienating Cloudlight customers and losing engineering talent, despite limited optical integration…
Western Digital's Q1 2027 revenue rose 55% to $4.38 billion as hyperscaler demand lifted non-GAAP EPS 161% to $4.64.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.